Volume 6, Issue 3 (9-2016)                   Iran J Ped Hematol Oncol 2016, 6(3): 172-181 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Eskandari F, Pourkarim H, Sahmani M, Goudarzi M, Mobarra N, Dehghanifard A, et al . Gene Expression and Promoter Methylation Status of VHL, Runx-3, E-cadherin, P15 and P16 Genes During EPO-Mediated Erythroid Differentiation of CD34+ Hematopoietic Stem Cells . Iran J Ped Hematol Oncol 2016; 6 (3) :172-181
URL: http://ijpho.ssu.ac.ir/article-1-264-en.html
Gene Expression and Promoter Methylation Status of VHL, Runx-3, E-cadherin, P15 and P16 Genes During EPO-Mediated Erythroid Differentiation of CD34+ Hematopoietic Stem Cells
Fatemeh Eskandari , Hoda Pourkarim , Mehdi Sahmani , Mehdi Goudarzi , Naser Mobarra , Ali Dehghanifard , Gholamreza Khamisipour , Nasim Kalantari , Hanieh Rahmani , Mehdi Azad *
Department of Medical laboratory sciences, Faculty of Allied Medicine, Qazvin University of Medical Sciences, Qazvin, Iran
Abstract:   (7645 Views)

Background: VHL (von Hippel-Lindau), Runx-3 (Runt-related transcription factor 3), E-cadherin (Epithelial cadherin), P15 (INK4a, cyclin dependent kinase inhibitor), and P16 (INK4b) genes are essential in hematopoiesis. The aim of this study was to explore the correlation between gene expression and promoter methylation in CD34+ stem cells before and after differentiation to erythroid lineage.

Materials and Methods: CD34+ hematopoietic stem cells were separated from umbilical cord blood using MidiMacs (positive selection) system. Expanded CD34+ stem cells were differentiated into erythroid lineage with human recombinant erythropoietin (EPO). DNA extraction was done by QIAamp DNA Mini Kit. RNA was extracted using RNase Mini plus Kit. MSP (Methylation specific PCR) technique was done for methylation assay. Methylation status and expression assay was done for VHL, Runx-3, E-cadherin, P15, and P16 genes  on both CD34+ stem cells and differentiated erythroid cells.

Results: The results showed that, before differentiation, P15 had comparative methylation pattern and average expression and it remained unchanged after differentiation (p=0.01). concerning P16, results revealed no methylation pattern and complete expression in absence of EPO and with EPO it changed to comparative status (p=0.01). E-cad and Runx-3 genes had relative methylation pattern and fully expression before and after differentiation but their expression after that, was increased and decreased  Respectively (p=0.04). VHL gene had no significant methylation status before or after differentiation and its expression was complete (p=0.01).

Conclusion: The obtained results indicated that promoter methylation of P15, P16, VHL, Runx3 and E-cad was one of the definitive expression control mechanism of these genes.

Keywords: Differentiation, EPO, Hematopoietic Stem Cells
Full-Text [PDF 372 kb]   (1676 Downloads)    
Type of Study: Research | Subject: Heart
Received: 2015/09/15 | Accepted: 2016/06/12 | Published: 2016/09/3
References
1. Ito Y, Bae S-C, Chuang LSH. The RUNX family: developmental regulators in cancer. Nature Reviews Cancer. 2015;15(2):81-95. [Article]
2. Van Wijnen AJ, Stein GS, Peter Gergen J, Groner Y, Hiebert SW, Ito Y, et al. Nomenclature for Runt-related(RUNX) proteins. Oncogene. 2004;23(24):4209-10. [Article]
3. Kitago M, Martinez SR, Nakamura T, Sim M-S, Hoon DS. Regulation of RUNX3 tumor suppressor gene expression in cutaneous melanoma. Clinical Cancer Research. 2009;15(9):2988-94. [Article]
4. Kalev‐Zylinska ML, Horsfield JA, Flores MVC, Postlethwait JH, Chau JY, Cattin PM, et al. Runx3 is required for hematopoietic development in zebrafish. Developmental dynamics. 2003;228(3):323-36. [Article]
5. Basak S, Desai DJ, Rho EH, Ramos R, Maurel P, Kim HA. E‐Cadherin enhances neuregulin signaling and promotes Schwann cell myelination. Glia. 2015. [Article]
6. Li D, Zhou J, Wang L, Shin ME, Su P, Lei X, et al. Integrated biochemical and mechanical signals regulate multifaceted human embryonic stem cell functions. The Journal of cell biology. 2010;191(3):631-44. [Article]
7. Harb N, Archer TK, Sato N. The Rho-Rock-Myosin signaling axis determines cell-cell integrity of self-renewing pluripotent stem cells. PLoS One. 2008;3(8):e3001. [Article]
8. Chowdhury F, Na S, Li D, Poh Y-C, Tanaka TS, Wang F, et al. Material properties of the cell dictate stress-induced spreading and differentiation in embryonic stem cells. Nature materials. 2010;9(1):82-8. [Article]
9. Bodoor K, Haddad Y, Alkhateeb A, Al-Abbadi A, Dowairi M, Magableh A, et al. DNA hypermethylation of cell cycle (p15 and p16) and apoptotic (p14, p53, DAPK and TMS1) genes in peripheral blood of leukemia patients. Asian Pac J Cancer Prev. 2014;15(1):75-84. [Article]
10. Zhang J-C, Gao B, Yu Z-T, Liu X-B, Lu J, Xie F, et al. Promoter hypermethylation of p14 ARF, RB, and INK4 gene family in hepatocellular carcinoma with hepatitis B virus infection. Tumor Biology. 2014;35(3):2795-802. [Article]
11. Kis A, Tatár TZ, Gáll T, Boda R, Tar I, Major T, et al. Frequency of Genetic and Epigenetic Alterations of p14ARF and p16INK4A in Head and Neck Cancer in a Hungarian Population. Pathology & Oncology Research. 2014;20(4):923-9. [Article]
12. Ren W-H, Li Y-W, Li R, Feng H-B, Wu J-L, Wang H-R. P15 gene methylation in hepatocellular carcinomas: a systematic review and meta-analysis. International journal of clinical and experimental medicine. 2015;8(4):4762. [Article]
13. Ji H, Ehrlich LI, Seita J, Murakami P, Doi A, Lindau P, et al. Comprehensive methylome map of lineage commitment from haematopoietic progenitors. Nature. 2010;467(7313):338-42. [Article]
14. Lyon S, Buonocore L, Miller M. Naturally occurring methylation inhibitor: DNA hypomethylation and hemoglobin synthesis in human K562 cells. Molecular and cellular biology. 1987;7(5):1759-63. [Article]
15. Armeanu S, Bühring H-J, Reuss-Borst M, Müller CA, Klein G. E-cadherin is functionally involved in the maturation of the erythroid lineage. The Journal of cell biology. 1995;131(1):243-9. [Article]
16. Seidl S, Ackermann J, Kaufmann H, Keck A, Nösslinger T, Zielinski CC, et al. DNA‐methylation analysis identifies the E‐cadherin gene as a potential marker of disease progression in patients with monoclonal gammopathies. Cancer. 2004;100(12):2598-606. [Article]
17. Esteller M. CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future. Oncogene. 2002;21(35):5427-40. [Article]
18. Quesnel B, Guillerm G, Vereecque R, Wattel E, Preudhomme C, Bauters F, et al. Methylation of the p15INK4b gene in myelodysplastic syndromes is frequent and acquired during disease progression. Blood. 1998;91(8):2985-90. [Article]
19. Hsu T. Complex cellular functions of the von Hippel–Lindau tumor suppressor gene: insights from model organisms. Oncogene. 2012;31(18):2247-57. [Article]
20. Mack FA, Patel JH, Biju MP, Haase VH, Simon MC. Decreased growth of Vhl−/− fibrosarcomas is associated with elevated levels of cyclin kinase inhibitors p21 and p27. Molecular and cellular biology. 2005;25(11):4565-78. [Article]
21. Dyke T. Inquiry; 1999: 4: 1 (Winter). 1999. [Article]
22. Burns CE, Traver D, Mayhall E, Shepard JL, Zon LI. Hematopoietic stem cell fate is established by the Notch–Runx pathway. Genes & development. 2005;19(19):2331-42. [Article]
23. Levanon D, Brenner O, Otto F, Groner Y. Runx3 knockouts and stomach cancer. EMBO reports. 2003;4(6):560-4. [Article]
24. Goel A, Arnold CN, Tassone P, Chang DK, Niedzwiecki D, Dowell JM, et al. Epigenetic inactivation of RUNX3 in microsatellite unstable sporadic colon cancers. International journal of cancer. 2004;112(5):754-9. [DOI]
Add your comments about this article : Your username or Email:
CAPTCHA
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Iranian Journal of Pediatric Hematology and Oncology

Designed & Developed by : Yektaweb